J. Goldman & Co LP - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 142 filers reported holding THERAPEUTICSMD INC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q4 2020$326,000
-40.5%
269,235
-22.4%
0.02%
-56.8%
Q3 2020$548,000
-3.9%
347,046
-23.8%
0.04%
+5.7%
Q2 2020$570,000
-59.0%
455,678
-65.3%
0.04%
-79.2%
Q1 2020$1,391,000
-78.6%
1,312,690
-51.1%
0.17%
-63.9%
Q4 2019$6,496,000
+43.8%
2,684,481
+115.7%
0.47%
+37.5%
Q3 2019$4,517,000
+3.0%
1,244,438
-26.2%
0.34%
+11.5%
Q2 2019$4,386,000
-54.6%
1,686,787
-14.9%
0.30%
-44.1%
Q1 2019$9,655,000
+54.6%
1,982,551
+21.0%
0.54%
+13.1%
Q4 2018$6,245,000
+245.2%
1,639,062
+494.3%
0.48%
+281.7%
Q3 2018$1,809,000
+23.6%
275,816
+17.5%
0.13%
+65.8%
Q2 2018$1,464,000
-59.8%
234,649
-68.6%
0.08%
-51.0%
Q1 2018$3,643,000
-58.3%
748,112
-48.3%
0.16%
-66.2%
Q4 2017$8,742,000
+102.9%
1,447,394
+77.7%
0.46%
+111.5%
Q3 2017$4,309,000
-13.2%
814,500
-13.6%
0.22%
-19.3%
Q2 2017$4,967,000
+515.5%
942,400
+740.6%
0.27%
+572.5%
Q1 2017$807,000
-78.6%
112,114
-82.8%
0.04%
-84.0%
Q4 2016$3,770,000
-21.2%
653,350
-7.0%
0.25%
-7.4%
Q3 2016$4,783,000
+237.5%
702,400
+190.4%
0.27%
+123.1%
Q3 2015$1,417,000241,8650.12%
Other shareholders
THERAPEUTICSMD INC shareholders Q1 2018
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 4,115,116$4,979,0001.13%
GMT CAPITAL CORP 5,986,062$7,243,0000.52%
Rubric Capital Management LP 4,520,610$5,470,0000.40%
Handelsinvest Investeringsforvaltning 1,200,000$1,446,0000.22%
RA Capital Management 7,812,500$9,453,0000.13%
Knights of Columbus Asset Advisors LLC 705,105$853,0000.09%
GSA CAPITAL PARTNERS LLP 385,106$466,0000.08%
C WorldWide Group Holding A/S 6,189,834$7,490,0000.08%
Virtu Financial LLC 568,171$687,0000.07%
Aristides Capital LLC 156,747$190,0000.06%
View complete list of THERAPEUTICSMD INC shareholders